CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $155K of Crinetics Pharmaceuticals, Inc.
Sold$155,190
$27.38Price
5,668Shares
−4%Stake
What CRNX did after the filing
- The stock from Fri, Dec 3 close, $24.66
- −12.6%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Jan 18 close.
Traded Wed, Dec 1. Filed Fri, Dec 3, 11:36 AM ET, during the session. Returns use the Dec 3 close and the Jan 18 close. Not investment advice.